Trademark: 87504901
Word
WHY FUNGUS IS YOUR GUT'S BEST FRIEND
Status
Dead
Status Code
606
Status Date
Monday, December 9, 2019
Serial Number
87504901
Mark Type
4000
Filing Date
Monday, June 26, 2017
Published for Opposition
Tuesday, March 13, 2018
Abandoned Date
Monday, December 9, 2019

Trademark Owner History
BIOHM HEALTH LLC - 1st New Owner After Publication
PathoBiome LLC - Owner At Publication

Classifications
5 Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; preparations in the nature of a vaginal probiotic for the treatment and/or prevention of bacterial or fungal vaginal infection; nutraceuticals for the treatment and/or prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and/or nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and/or bacterial probiotics, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; diagnostic colon test kit comprised of medical diagnostic reagents and assays for the detection of cancer, polyps, ulcers, inflammation, infection, bacteria and microorganisms; diagnostic colon cancer test kit comprised of medical diagnostic reagents and assays; colorectal cancer screening test kit comprised of medical diagnostic reagents and assays
41 Educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and how to have and maintain and/or monitor a heathy gastrointestinal tract; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and how to have and maintain and/or monitor a heathy large intestine
44 Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; medical diagnostic testing services to apprise individuals and/or animals of the status of the gastrointestinal tract; medical diagnostic testing services to apprise individuals and/or animals of the status of the large intestine; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the gastrointestinal tract; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the large intestine

Trademark Events
Dec 9, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 9, 2019
Abandonment - No Use Statement Filed
May 10, 2019
Notice Of Approval Of Extension Request E-Mailed
May 8, 2019
Extension 2 Granted
May 8, 2019
Extension 2 Filed
May 8, 2019
Teas Extension Received
Jan 30, 2019
Automatic Update Of Assignment Of Ownership
Oct 30, 2018
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2018
Extension 1 Granted
Oct 26, 2018
Extension 1 Filed
Oct 26, 2018
Teas Extension Received
May 8, 2018
Noa E-Mailed - Sou Required From Applicant
Mar 13, 2018
Official Gazette Publication Confirmation E-Mailed
Mar 13, 2018
Published For Opposition
Feb 21, 2018
Notification Of Notice Of Publication E-Mailed
Feb 1, 2018
Approved For Pub - Principal Register
Feb 1, 2018
Examiner's Amendment Entered
Feb 1, 2018
Notification Of Examiners Amendment E-Mailed
Feb 1, 2018
Examiners Amendment E-Mailed
Feb 1, 2018
Examiners Amendment -Written
Feb 1, 2018
Teas/Email Correspondence Entered
Jan 31, 2018
Correspondence Received In Law Office
Jan 31, 2018
Teas Response To Office Action Received
Aug 2, 2017
Notification Of Non-Final Action E-Mailed
Aug 2, 2017
Non-Final Action E-Mailed
Aug 2, 2017
Non-Final Action Written
Jul 31, 2017
Assigned To Examiner
Jul 1, 2017
New Application Office Supplied Data Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24